NVAX
Novavax Inc
12.80$
+15.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -179.7% | -60.7% | -89.0% | 75.6% | -171.4% | -196.1% | -27.8% | -53.3% | 153.0% | -26.8% | -23.2% | -133.0% | -9.5% | |
| 51.3% | 3.7% | 12.9% | 2.7% | 15.0% | 14.2% | 1.3% | 3.2% | 9.3% | 3.5% | 2.2% | 5.4% | 4.3% | |
| 94.1% | 5.4% | 12.3% | 3.4% | 14.3% | 11.8% | 1.5% | 3.9% | 12.1% | 5.4% | 5.5% | 14.3% | 7.8% | |
| 162.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 199.3% | -17.0% | 36.5% | 27.7% | -62.0% | -55.1% | -110.9% | -100.5% | 235.5% | -50.1% | -17.9% | 39.5% | 21.7% | |
| 83.4% | 3.1% | 7.7% | 0.8% | 2.4% | 2.6% | 0.2% | 0.1% | 2.9% | 1.4% | 0.9% | 2.2% | 1.6% | |
| -83.4% | -3.1% | -7.7% | -89.7% | 37.8% | 163.1% | -11.0% | 46.4% | -193.8% | 13.9% | -20.3% | 61.5% | -26.5% | |
| – | – | – | – | – | – | – | -2.2% | 1.2% | -0.2% | -5.8% | 14.4% | 0.1% | |
| 8.0% | – | – | – | -0.6% | -3.1% | -0.3% | -0.3% | 59.1% | -4.3% | 32.9% | -82.8% | 8.3% | |
| 893.4% | 34.5% | 6.3% | 62.1% | -0.1% | -3.9% | -1.1% | -0.4% | 60.2% | -4.5% | 27.0% | 16.5% | 20.0% | |
| 672.7% | -28.3% | -93.6% | 48.0% | -126.6% | -49.0% | -40.0% | -4.0% | 20.4% | -18.6% | -16.6% | -55.2% | -16.3% | |
| -263.1% | -63.8% | -96.8% | 74.9% | -173.7% | -198.6% | -28.1% | -53.4% | 150.2% | -28.2% | -24.2% | -130.8% | -10.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.